Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
- PMID: 31747739
- DOI: 10.1056/NEJMc1913157
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
Comment in
-
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.N Engl J Med. 2019 Nov 21;381(21):2076-2077. doi: 10.1056/NEJMc1913157. N Engl J Med. 2019. PMID: 31747740 No abstract available.
Comment on
-
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical